Empowering African Women: How a Ring is Providing New Security Against HIV

New ⁢Long-Acting HIV​ Prevention Tool for Women Becomes Available​ in East Africarn

By PAULINE KAIRU

The introduction⁤ of the dapivirine vaginal ring, also known as the DapiRing, heralds⁢ a new era for women’s access to HIV prevention tools. With regulatory approval ‍in 11 Eastern and Southern African countries,‌ including Kenya, Uganda, and ⁢Rwanda where women account for a significant proportion of people living ⁣with HIV,⁣ this long-acting pre-exposure prophylaxis (PrEP) tool is set ​to make a positive impact on​ women’s health.

Continuous Protection

The dapivirine‌ vaginal ring ⁣offers discreet and continuous protection against HIV during sexual activity. This small silicone ring worn internally slowly releases the antiretroviral drug dapivirine⁣ over a month to prevent an infection from establishing.

Empowerment Through Discretion

This innovative tool provides ‍women an option that is entirely ⁢within their ⁤control. ⁣It eliminates the reliance on male partners’ cooperation and minimizes upkeep as it only needs to be replaced once per month.

Partnership for Access

Miles Kemplay, ⁣Executive Director⁣ of Sexual and Reproductive Health Rights at Children’s ‍Investment Fund Foundation (CIFF),‌ emphasizes that affordability has been a barrier to accessing this option. CIFF’s collaboration with the Global Fund seeks to ‍bridge this gap⁤ through an initiative ⁢aimed at making 150,000 rings available.

Innovative Development

Manufactured by Sever Pharma Solutions⁤ in Sweden exclusively for the Population Council, these‌ rings⁢ signal significant ​progress in HIV prevention efforts for Sub-Saharan Africa where most new infections occur among women.

A⁢ next-generation⁤ three-month‍ PrEP​ ring is also on its way through regulatory review soon.

Sustainable Market Access

This initiative aims not only‍ at providing immediate⁤ access but​ also ensuring long-term sustainability by facilitating​ market ‍adoption while driving down costs.

For effective implementation starting October2024-2025), collaborations⁢ involving CIFF alongside other ⁤partners aim at‍ setting up groundwork expanded adoption while exploring avenues that will lead to further price reductions.

The ⁣cost of ⁣one-month​ PrEP ring currently stands at ⁤$12.8‌ but plans⁣ are underway towards bridging affordable access by rolling out ‌three-month rings priced under $16 – almost 60% more cost-effective compared⁣ with individual monthly procurement excluding​ distribution costs.

These partnerships have identified several ‌opportunities aimed at reducing price tag even further.

Tackling Major Health Challenges
Although there have been substantial gains made towards combating global challenges​ such as ⁣HIV/AIDS infections estimated globally at 39.9 million despite having reduced significantly over years; strategic ‌measures are needed ⁤strategically focus especially amongst‍ marginalized communities​ such as young girls which often face gender inequality obstacles amidst limited healthcare accessibility resulting into high infection rates against ‍girls/women.

Amongst sub-Saharan Africa ​population often​ faces ⁢cultural norms practices,”‌ said Peter Sands – Global fund executive director targeted investments ⁤close into innovative preventive interventions like introducing today’s intervention makes ⁣noteworthy revolutionizing impact,”​ he⁤ added.